ArticleMaterials (Basel, Switzerland)2026
Improved Toughness of PLA/PBAT/Modified Bamboo Powder Composites Through Interfacial Regulation.
Article in Materials (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The incorporation of abundant natural bamboo fiber (BF) into biodegradable polymers has emerged as a promising strategy to develop environmentally friendly materials. However, the poor interfacial compatibility between BF and biodegradable polymers has led to reduced performance, especially deteriorated toughness, and has limited the practical applications of bamboo-plastic composites. In this study, a compatible modifier, polydopamine (PDA), was employed to modify the surface of natural BF, and poly(lactic acid)/poly(butylene adipate-co-terephthalate) (PLA/PBAT) bamboo-plastic composites were fabricated via melt blending. And then, a commercial multifunctional compatibilizer (AX8900) was introduced to further enhance the interfacial compatibility and physical properties of the composite. After adding 20 wt% modified BF and 2 wt% compatibilizer, the composite exhibited a better notch impact strength (9.7 kJ/m
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.